0.99
price down icon6.60%   -0.07
after-market 시간 외 거래: 1.06 0.07 +7.07%
loading

Unity Biotechnology Inc (UBX) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
1.02%
7.599
7.677 14.58 11.85 10.56
Interest Income/Expense
100.00%
-
0.001 0.566 0.883 1.002
Operating Income/Loss
1.02%
-7.599
-7.677 -14.58 -11.85 -10.56
Income/Loss From Continuing Operations Before Tax
33.41%
-5.79
-4.34 -14.78 -15.46 -5.279
Income/Loss From Continuing Operations After Tax
33.41%
-5.79
-4.34 -14.78 -15.46 -5.279
Net Income/Loss
33.41%
-5.79
-4.34 -14.78 -15.46 -5.279
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,034%
16.79
0.3269 14.60 14.43 14.31
Diluted Average Shares
5,034%
16.79
0.3269 14.60 14.43 14.31
Basic Earnings Per Share
41.67%
-0.34
-0.24 -1.01 -1.07 -0.37
Diluted Earnings Per Share
41.67%
-0.34
-0.24 -1.01 -1.07 -0.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
자본화:     |  볼륨(24시간):